Posted by Clinical Lab Products | May 2, 2005 | Allergy & Autoimmune, Cancer |
By Gary Tufel Rheumatoid arthritis (RA) is a chronic, debilitating disease that affects 1% of the US population—about 2.1 million Americans. Currently, the cause of RA is unknown, although there are several theories. While there is no cure,
Read MorePosted by Clinical Lab Products | Apr 10, 2005 | Cancer, Miscellaneous |
COLA Announces New QMS Accreditation Program COLA has launched a quality management systems (QMS) accreditation program to assist laboratories faced with the challenge of maintaining a culture of quality. The program is a systems-based management
Read MorePosted by Clinical Lab Products | Feb 6, 2005 | Cancer, Miscellaneous |
By Nicholas Borgert Widespread use of the fibrous silicate material asbestos may be on its way out, but concern about the diseases it causes has caught the eye of at least one test developer: Fujirebio Diagnostics Inc (FDI). Asbestos has been u
Read MorePosted by Clinical Lab Products | Jul 12, 2004 | Cancer, Miscellaneous, Osteoporosis |
Roche and Premier Continue Partnership Roche Diagnostics Corp and Premier Purchasing Partners LLP have signed a 3-year agreement in which Roche will continue to provide instruments, reagents, and consumables to Premier members. The contract includ
Read MorePosted by Clinical Lab Products | Jun 2, 2004 | Cancer, Miscellaneous |
By Gary Tufel Obesity has been previously acknowledged as a causative factor for a range of diseases, including cardiac problems and diabetes. Now research has clearly demonstrated obesity’s link to cancer. According to Colleen Doyle, MS, R
Read More